Register for our free email digests:
Agilent Technologies Inc.
www.agilent.com
Latest From Agilent Technologies Inc.
Global Device Approvals Snapshot: 11-17 June 2019
A snapshot of global medical device approvals captured during the past week in Medtech Insight's Approvals Tracker, including a PMA supplement for Agilent’s PD-L1 IHC 22C3 pharmDx companion diagnostic for Merck’s Keytruda (pembrolizumab), an anti-PD-1 drug, for patients with head and neck squamous cell carcinoma. The US FDA also approved a supplement for the Cochlear Nucleus Profile Plus Series Cochlear Implant, designed to be safe with magnetic resonance imaging.
Global Device Approvals, Weekly Snapshot: Aug. 13-19, 2018
A snapshot of global medical device and diagnostics approvals recorded during the past week in Medtech Insight's Approvals Tracker. This week, two Health Canada approvals, and more.
Appointments: Senior Hires At Allergan, Novartis, Array Biopharma, Zelluna Immunotherapy, Grail, Alzheon And Sigilon Therapeutics
Pfizer Oncology has lost its CMO to Allergan, while Novartis beefs up its ethical leadership, Array Biopharma appoints a new chair and Sigilon raids Bioverativ for its new CEO.
Was PD-L1 Test To Blame For Failure Of Bristol's Opdivo In '026 Trial?
NEJM editorial suggests that differences in PD-L1 testing may explain why Bristol's Opdivo failed in first-line lung cancer trial whereas Merck's Keytruda succeeded, but some analysts aren't so sure.
Company Information
- Industry
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
- Nanotechnology, Chips, etc.
-
Drug Discovery Tools
- In Vitro Diagnostics
- Research, Analytical Equipment & Supplies
- Therapeutic Areas
- Non-Specific
- Alias(es)
- Ownership
- Public
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
- Agilent Technologies Inc.
- Senior Management
-
Mike P McMullen, Pres. & CEO
Didier Hirsch, SVP, CFO
Samraat Raha, SVP, Strategy & Corp. Dev.
Darlene Solomon, PhD, SVP, CTO
Rodney Gonsalves, VP, Corporate Controller & Principal Acctg. Office
Guillermo Gualino, VP, Treasurer
Nancy Lelicoff, VP, RA, Quality and Clinical Affairs - Contact Info
-
Agilent Technologies Inc.
Phone: (408) 345-8886
5301 Stevens Creek Blvd.
Santa Clara, CA 95051
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice